nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—hypertension—adrenal gland cancer	0.425	1	CtDrD
Captopril—REN—adrenal gland cancer	0.412	0.902	CbGaD
Captopril—ABCB1—adrenal gland cancer	0.0449	0.0983	CbGaD
Captopril—REN—zona fasciculata of adrenal gland—adrenal gland cancer	0.0127	0.151	CbGeAlD
Captopril—REN—zona glomerulosa of adrenal gland—adrenal gland cancer	0.0111	0.132	CbGeAlD
Captopril—REN—renal vein—adrenal gland cancer	0.0108	0.128	CbGeAlD
Captopril—REN—posterior vena cava—adrenal gland cancer	0.00789	0.0934	CbGeAlD
Captopril—REN—renal artery—adrenal gland cancer	0.00727	0.0861	CbGeAlD
Captopril—F2—posterior vena cava—adrenal gland cancer	0.00551	0.0652	CbGeAlD
Captopril—REN—sympathetic nervous system—adrenal gland cancer	0.00372	0.0441	CbGeAlD
Captopril—REN—vein—adrenal gland cancer	0.00348	0.0412	CbGeAlD
Captopril—ACE—renal artery—adrenal gland cancer	0.0031	0.0367	CbGeAlD
Captopril—F2—vein—adrenal gland cancer	0.00243	0.0288	CbGeAlD
Captopril—REN—urine—adrenal gland cancer	0.00204	0.0241	CbGeAlD
Captopril—ACE—sympathetic nervous system—adrenal gland cancer	0.00159	0.0188	CbGeAlD
Captopril—ACE—vein—adrenal gland cancer	0.00148	0.0176	CbGeAlD
Captopril—F2—urine—adrenal gland cancer	0.00142	0.0168	CbGeAlD
Captopril—ACE—urine—adrenal gland cancer	0.000869	0.0103	CbGeAlD
Captopril—LTA4H—adrenal cortex—adrenal gland cancer	0.0007	0.00829	CbGeAlD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—adrenal gland cancer	0.000602	0.0179	CbGpPWpGaD
Captopril—MMP2—Plasma membrane estrogen receptor signaling—IGF1R—adrenal gland cancer	0.000593	0.0176	CbGpPWpGaD
Captopril—LTA4H—gonad—adrenal gland cancer	0.00058	0.00686	CbGeAlD
Captopril—LTA4H—cardiac atrium—adrenal gland cancer	0.000579	0.00685	CbGeAlD
Captopril—LTA4H—pituitary gland—adrenal gland cancer	0.000566	0.0067	CbGeAlD
Captopril—MMP9—FGF signaling pathway—SPRY2—adrenal gland cancer	0.000564	0.0168	CbGpPWpGaD
Captopril—REN—adrenal cortex—adrenal gland cancer	0.00054	0.0064	CbGeAlD
Captopril—F2—Regulation of IGF Activity by IGFBP—IGF2—adrenal gland cancer	0.00053	0.0158	CbGpPWpGaD
Captopril—MMP9—Syndecan-1-mediated signaling events—PRKACA—adrenal gland cancer	0.000523	0.0155	CbGpPWpGaD
Captopril—MMP9—Osteopontin-mediated events—CDC42—adrenal gland cancer	0.000522	0.0155	CbGpPWpGaD
Captopril—LTA4H—adrenal gland—adrenal gland cancer	0.000505	0.00598	CbGeAlD
Captopril—MMP2—adrenal cortex—adrenal gland cancer	0.000497	0.00588	CbGeAlD
Captopril—REN—Peptide hormone metabolism—POMC—adrenal gland cancer	0.00046	0.0137	CbGpPWpGaD
Captopril—REN—cardiac atrium—adrenal gland cancer	0.000447	0.00529	CbGeAlD
Captopril—REN—pituitary gland—adrenal gland cancer	0.000437	0.00517	CbGeAlD
Captopril—MMP2—AGE/RAGE pathway—CDC42—adrenal gland cancer	0.000435	0.0129	CbGpPWpGaD
Captopril—CYP2D6—urine—adrenal gland cancer	0.000425	0.00503	CbGeAlD
Captopril—MMP2—gonad—adrenal gland cancer	0.000411	0.00487	CbGeAlD
Captopril—MMP2—cardiac atrium—adrenal gland cancer	0.000411	0.00486	CbGeAlD
Captopril—MMP2—pituitary gland—adrenal gland cancer	0.000401	0.00475	CbGeAlD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—adrenal gland cancer	0.000395	0.0117	CbGpPWpGaD
Captopril—REN—adrenal gland—adrenal gland cancer	0.00039	0.00462	CbGeAlD
Captopril—MMP2—FOXM1 transcription factor network—RB1—adrenal gland cancer	0.00039	0.0116	CbGpPWpGaD
Captopril—MMP9—Plasma membrane estrogen receptor signaling—IGF1R—adrenal gland cancer	0.000389	0.0116	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—adrenal gland cancer	0.000379	0.0113	CbGpPWpGaD
Captopril—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000366	0.0109	CbGpPWpGaD
Captopril—MMP2—adrenal gland—adrenal gland cancer	0.000359	0.00424	CbGeAlD
Captopril—MMP9—Endochondral Ossification—PRKACA—adrenal gland cancer	0.000345	0.0102	CbGpPWpGaD
Captopril—Enalapril—ABCB1—adrenal gland cancer	0.000344	1	CrCbGaD
Captopril—MMP2—FOXM1 transcription factor network—CDKN2A—adrenal gland cancer	0.000343	0.0102	CbGpPWpGaD
Captopril—REN—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.000328	0.00975	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.000328	0.00974	CbGpPWpGaD
Captopril—MMP9—adrenal gland—adrenal gland cancer	0.000312	0.00369	CbGeAlD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000305	0.00905	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—adrenal gland cancer	0.000299	0.00889	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—RB1—adrenal gland cancer	0.000297	0.00882	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.000294	0.00875	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—CDC42—adrenal gland cancer	0.000285	0.00847	CbGpPWpGaD
Captopril—LTA4H—Metabolism—SDHB—adrenal gland cancer	0.000282	0.00839	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—IGF2—adrenal gland cancer	0.000282	0.00837	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—IGF1R—adrenal gland cancer	0.000272	0.00809	CbGpPWpGaD
Captopril—F2—adrenal gland—adrenal gland cancer	0.000272	0.00322	CbGeAlD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.000263	0.00783	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—adrenal gland cancer	0.000249	0.00739	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—CDC42—adrenal gland cancer	0.000235	0.00699	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NR5A1—adrenal gland cancer	0.000234	0.00694	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000222	0.0066	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.000215	0.00639	CbGpPWpGaD
Captopril—ACE—Peptide hormone metabolism—POMC—adrenal gland cancer	0.000205	0.0061	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.000205	0.00608	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—SPARC—adrenal gland cancer	0.0002	0.00595	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TERT—adrenal gland cancer	0.000198	0.00589	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—adrenal gland cancer	0.000196	0.00583	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000195	0.00579	CbGpPWpGaD
Captopril—ACE—gonad—adrenal gland cancer	0.000191	0.00226	CbGeAlD
Captopril—ACE—cardiac atrium—adrenal gland cancer	0.00019	0.00225	CbGeAlD
Captopril—MMP9—TWEAK Signaling Pathway—CTNNB1—adrenal gland cancer	0.000188	0.00559	CbGpPWpGaD
Captopril—ACE—pituitary gland—adrenal gland cancer	0.000186	0.0022	CbGeAlD
Captopril—LTA4H—Metabolism—SDHD—adrenal gland cancer	0.000182	0.00541	CbGpPWpGaD
Captopril—LTA4H—Metabolism—RRM1—adrenal gland cancer	0.000182	0.00541	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CDC42—adrenal gland cancer	0.000179	0.00532	CbGpPWpGaD
Captopril—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—adrenal gland cancer	0.000179	0.00531	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.000176	0.00524	CbGpPWpGaD
Captopril—ALB—adrenal gland—adrenal gland cancer	0.000174	0.00206	CbGeAlD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.000171	0.00509	CbGpPWpGaD
Captopril—ACE—adrenal gland—adrenal gland cancer	0.000166	0.00197	CbGeAlD
Captopril—MMP9—CXCR4-mediated signaling events—BAD—adrenal gland cancer	0.000164	0.00488	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—EGFR—adrenal gland cancer	0.000162	0.00482	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.000158	0.0047	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.000158	0.00469	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NR5A1—adrenal gland cancer	0.000153	0.00455	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.000149	0.00444	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—adrenal gland cancer	0.000149	0.00443	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—RB1—adrenal gland cancer	0.000149	0.00442	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000148	0.00441	CbGpPWpGaD
Captopril—ACE—Peptide hormone metabolism—CTNNB1—adrenal gland cancer	0.000147	0.00436	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—MED12—adrenal gland cancer	0.00014	0.00417	CbGpPWpGaD
Captopril—LTA4H—Metabolism—MED12—adrenal gland cancer	0.000136	0.00403	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.000134	0.00399	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—SPARC—adrenal gland cancer	0.000131	0.0039	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—IGF2—adrenal gland cancer	0.00013	0.00387	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—REN—adrenal gland cancer	0.00013	0.00385	CbGpPWpGaD
Captopril—ALB—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.000129	0.00382	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.000125	0.00371	CbGpPWpGaD
Captopril—MMP2—Axon guidance—CDC42—adrenal gland cancer	0.000122	0.00362	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000121	0.0036	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.000117	0.00348	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000117	0.00347	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—REN—adrenal gland cancer	0.000116	0.00346	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.000115	0.00341	CbGpPWpGaD
Captopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000115	0.0034	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.000112	0.00334	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—RB1—adrenal gland cancer	0.000112	0.00332	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—BAD—adrenal gland cancer	0.000108	0.00322	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—EGFR—adrenal gland cancer	0.000106	0.00316	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—SPARC—adrenal gland cancer	0.000105	0.00311	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000104	0.00309	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.000104	0.00308	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	9.97e-05	0.00296	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PRKACA—adrenal gland cancer	9.9e-05	0.00294	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.67e-05	0.00287	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MED12—adrenal gland cancer	9.21e-05	0.00274	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—PTGS2—adrenal gland cancer	9.19e-05	0.00273	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	8.98e-05	0.00267	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—GNRH1—adrenal gland cancer	8.9e-05	0.00264	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CDC42—adrenal gland cancer	8.69e-05	0.00258	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—POMC—adrenal gland cancer	8.68e-05	0.00258	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—EGFR—adrenal gland cancer	8.67e-05	0.00258	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GNRHR—adrenal gland cancer	8.39e-05	0.00249	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	8.37e-05	0.00249	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TP53—adrenal gland cancer	8.31e-05	0.00247	CbGpPWpGaD
Captopril—ABCB1—adrenal cortex—adrenal gland cancer	8.11e-05	0.000959	CbGeAlD
Captopril—F2—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	8.07e-05	0.0024	CbGpPWpGaD
Captopril—LTA4H—Metabolism—GNAS—adrenal gland cancer	8.02e-05	0.00238	CbGpPWpGaD
Captopril—MMP9—Axon guidance—CDC42—adrenal gland cancer	7.99e-05	0.00237	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—TSHR—adrenal gland cancer	7.93e-05	0.00236	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ABCB1—adrenal gland cancer	7.87e-05	0.00234	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	7.63e-05	0.00227	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GNRHR—adrenal gland cancer	7.62e-05	0.00226	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—adrenal gland cancer	7.54e-05	0.00224	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	7.29e-05	0.00217	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—adrenal gland cancer	7.28e-05	0.00216	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—IGF2—adrenal gland cancer	7.22e-05	0.00215	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	7.09e-05	0.00211	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	6.88e-05	0.00204	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—adrenal gland cancer	6.72e-05	0.002	CbGpPWpGaD
Captopril—ABCB1—gonad—adrenal gland cancer	6.71e-05	0.000795	CbGeAlD
Captopril—F2—Metabolism of proteins—REN—adrenal gland cancer	6.56e-05	0.00195	CbGpPWpGaD
Captopril—ABCB1—pituitary gland—adrenal gland cancer	6.55e-05	0.000775	CbGeAlD
Captopril—MMP9—Spinal Cord Injury—EGFR—adrenal gland cancer	6.52e-05	0.00194	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—IGF2—adrenal gland cancer	6.46e-05	0.00192	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—CTNNB1—adrenal gland cancer	6.2e-05	0.00184	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	6.14e-05	0.00182	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—POMC—adrenal gland cancer	6.08e-05	0.00181	CbGpPWpGaD
Captopril—F2—Hemostasis—SPARC—adrenal gland cancer	6.03e-05	0.00179	CbGpPWpGaD
Captopril—ABCB1—adrenal gland—adrenal gland cancer	5.85e-05	0.000693	CbGeAlD
Captopril—MMP9—Signaling Pathways—GNRHR—adrenal gland cancer	5.83e-05	0.00173	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—IGF2—adrenal gland cancer	5.81e-05	0.00173	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CDC42—adrenal gland cancer	5.7e-05	0.00169	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—EGFR—adrenal gland cancer	5.65e-05	0.00168	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—adrenal gland cancer	5.47e-05	0.00163	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.42e-05	0.00161	CbGpPWpGaD
Captopril—LTA4H—Metabolism—POMC—adrenal gland cancer	5.4e-05	0.00161	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ZNRF3—adrenal gland cancer	5.1e-05	0.00151	CbGpPWpGaD
Captopril—F2—Hemostasis—PRKACA—adrenal gland cancer	5.09e-05	0.00151	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GNRH1—adrenal gland cancer	5.03e-05	0.00149	CbGpPWpGaD
Captopril—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.01e-05	0.00149	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	4.64e-05	0.00138	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—GNAS—adrenal gland cancer	4.61e-05	0.00137	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GNRH1—adrenal gland cancer	4.57e-05	0.00136	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.53e-05	0.00135	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GNRHR—adrenal gland cancer	4.5e-05	0.00134	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TSHR—adrenal gland cancer	4.48e-05	0.00133	CbGpPWpGaD
Captopril—MMP2—Axon guidance—EGFR—adrenal gland cancer	4.43e-05	0.00132	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	4.38e-05	0.0013	CbGpPWpGaD
Captopril—F2—Hemostasis—CDC42—adrenal gland cancer	4.32e-05	0.00128	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—POMC—adrenal gland cancer	4.31e-05	0.00128	CbGpPWpGaD
Captopril—LTA4H—Metabolism—PTGS2—adrenal gland cancer	4.31e-05	0.00128	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SH3KBP1—adrenal gland cancer	4.18e-05	0.00124	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	4.18e-05	0.00124	CbGpPWpGaD
Captopril—F2—Hemostasis—IGF2—adrenal gland cancer	4.16e-05	0.00124	CbGpPWpGaD
Captopril—F2—Hemostasis—GNAS—adrenal gland cancer	4.12e-05	0.00123	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	4.08e-05	0.00121	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TSHR—adrenal gland cancer	4.07e-05	0.00121	CbGpPWpGaD
Captopril—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.06e-05	0.00121	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CTNNB1—adrenal gland cancer	3.99e-05	0.00119	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ZNRF3—adrenal gland cancer	3.93e-05	0.00117	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—POMC—adrenal gland cancer	3.88e-05	0.00115	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.67e-05	0.00109	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	3.6e-05	0.00107	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	3.56e-05	0.00106	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GNRH1—adrenal gland cancer	3.49e-05	0.00104	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.36e-05	0.000999	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	3.32e-05	0.000987	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—IGF2—adrenal gland cancer	3.27e-05	0.000973	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	3.2e-05	0.000952	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SPRY2—adrenal gland cancer	3.19e-05	0.000949	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EGFR—adrenal gland cancer	3.16e-05	0.000939	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	3.11e-05	0.000925	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TSHR—adrenal gland cancer	3.11e-05	0.000925	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—POMC—adrenal gland cancer	3.11e-05	0.000923	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CTNNB1—adrenal gland cancer	3.08e-05	0.000915	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MEN1—adrenal gland cancer	2.93e-05	0.00087	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PRKACA—adrenal gland cancer	2.92e-05	0.000868	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EGFR—adrenal gland cancer	2.9e-05	0.000863	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CTNNB1—adrenal gland cancer	2.77e-05	0.000823	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CDC42—adrenal gland cancer	2.73e-05	0.000811	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.73e-05	0.00081	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GNRH1—adrenal gland cancer	2.7e-05	0.000801	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	2.67e-05	0.000795	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—adrenal gland cancer	2.67e-05	0.000793	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CTNNB1—adrenal gland cancer	2.62e-05	0.000778	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GNAS—adrenal gland cancer	2.61e-05	0.000775	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.52e-05	0.000749	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CDC42—adrenal gland cancer	2.48e-05	0.000736	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SPRY2—adrenal gland cancer	2.47e-05	0.000733	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSHR—adrenal gland cancer	2.4e-05	0.000714	CbGpPWpGaD
Captopril—ALB—Hemostasis—SPARC—adrenal gland cancer	2.39e-05	0.000711	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GNAS—adrenal gland cancer	2.37e-05	0.000703	CbGpPWpGaD
Captopril—ALB—Metabolism—SDHB—adrenal gland cancer	2.34e-05	0.000694	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	2.28e-05	0.000678	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MEN1—adrenal gland cancer	2.26e-05	0.000672	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PRKACA—adrenal gland cancer	2.23e-05	0.000664	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—POMC—adrenal gland cancer	2.18e-05	0.000649	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	2.16e-05	0.000641	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—adrenal gland cancer	2.07e-05	0.000616	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SDHB—adrenal gland cancer	2.05e-05	0.000608	CbGpPWpGaD
Captopril—ALB—Hemostasis—PRKACA—adrenal gland cancer	2.02e-05	0.0006	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SDHB—adrenal gland cancer	1.93e-05	0.000573	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDC42—adrenal gland cancer	1.9e-05	0.000563	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.84e-05	0.000546	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF2—adrenal gland cancer	1.83e-05	0.000543	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GNAS—adrenal gland cancer	1.81e-05	0.000538	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1R—adrenal gland cancer	1.77e-05	0.000525	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—POMC—adrenal gland cancer	1.75e-05	0.000522	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.75e-05	0.000519	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PRKACA—adrenal gland cancer	1.73e-05	0.000513	CbGpPWpGaD
Captopril—ALB—Hemostasis—CDC42—adrenal gland cancer	1.71e-05	0.000509	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.68e-05	0.000499	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF2—adrenal gland cancer	1.65e-05	0.000491	CbGpPWpGaD
Captopril—ALB—Hemostasis—GNAS—adrenal gland cancer	1.64e-05	0.000486	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—POMC—adrenal gland cancer	1.59e-05	0.000474	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CTNNB1—adrenal gland cancer	1.56e-05	0.000463	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.53e-05	0.000455	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TERT—adrenal gland cancer	1.52e-05	0.000452	CbGpPWpGaD
Captopril—ALB—Metabolism—RRM1—adrenal gland cancer	1.51e-05	0.000447	CbGpPWpGaD
Captopril—ALB—Metabolism—SDHD—adrenal gland cancer	1.51e-05	0.000447	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.5e-05	0.000446	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDC42—adrenal gland cancer	1.46e-05	0.000435	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.42e-05	0.000421	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF2—adrenal gland cancer	1.41e-05	0.000419	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GNAS—adrenal gland cancer	1.4e-05	0.000416	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.39e-05	0.000413	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1R—adrenal gland cancer	1.36e-05	0.000405	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—BAD—adrenal gland cancer	1.32e-05	0.000393	CbGpPWpGaD
Captopril—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.32e-05	0.000392	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.32e-05	0.000392	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—adrenal gland cancer	1.32e-05	0.000392	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SDHD—adrenal gland cancer	1.24e-05	0.000369	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—RRM1—adrenal gland cancer	1.24e-05	0.000369	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.24e-05	0.000369	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—POMC—adrenal gland cancer	1.22e-05	0.000362	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—BRAF—adrenal gland cancer	1.2e-05	0.000358	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.19e-05	0.000354	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TERT—adrenal gland cancer	1.17e-05	0.000349	CbGpPWpGaD
Captopril—ALB—Metabolism—MED12—adrenal gland cancer	1.12e-05	0.000333	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BAD—adrenal gland cancer	1.02e-05	0.000303	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1e-05	0.000298	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	9.99e-06	0.000297	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MED12—adrenal gland cancer	9.83e-06	0.000292	CbGpPWpGaD
Captopril—F2—Signaling Pathways—POMC—adrenal gland cancer	9.41e-06	0.00028	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BRAF—adrenal gland cancer	9.3e-06	0.000276	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MED12—adrenal gland cancer	9.26e-06	0.000275	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—adrenal gland cancer	9.01e-06	0.000268	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CTNNB1—adrenal gland cancer	8.7e-06	0.000259	CbGpPWpGaD
Captopril—ALB—Metabolism—PRKACA—adrenal gland cancer	8.19e-06	0.000243	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	8e-06	0.000238	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PRKACA—adrenal gland cancer	7.17e-06	0.000213	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—adrenal gland cancer	6.89e-06	0.000205	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	6.76e-06	0.000201	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNB1—adrenal gland cancer	6.72e-06	0.0002	CbGpPWpGaD
Captopril—ALB—Metabolism—GNAS—adrenal gland cancer	6.63e-06	0.000197	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—adrenal gland cancer	6.51e-06	0.000193	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GNAS—adrenal gland cancer	5.81e-06	0.000173	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—adrenal gland cancer	5.79e-06	0.000172	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GNAS—adrenal gland cancer	5.48e-06	0.000163	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	5.38e-06	0.00016	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—adrenal gland cancer	5.32e-06	0.000158	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—adrenal gland cancer	5.23e-06	0.000155	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—adrenal gland cancer	4.47e-06	0.000133	CbGpPWpGaD
Captopril—ALB—Metabolism—POMC—adrenal gland cancer	4.47e-06	0.000133	CbGpPWpGaD
Captopril—ABCB1—Metabolism—POMC—adrenal gland cancer	3.91e-06	0.000116	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—POMC—adrenal gland cancer	3.69e-06	0.00011	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—adrenal gland cancer	3.56e-06	0.000106	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—adrenal gland cancer	3.12e-06	9.28e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	2.94e-06	8.74e-05	CbGpPWpGaD
